Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1457942

Cover Image

PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1457942

Laboratory Informatics Market Size and Share Analysis by Product, Delivery Mode, Component, Industry - Global Industry Demand Forecast to 2030

PUBLISHED:
PAGES: 290 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4900
Printable PDF (Group User License)
USD 6400
Printable PDF (Enterprise License)
USD 8400

Add to Cart

The laboratory informatics market had a size of USD 4,376.2 million in 2023, which will power at a compound annual growth rate of 11.4% by 2024- 2030, touching USD 9,176.6 million by 2030. The industry growth has a lot to do with the surge in the demand for lab automation, along with biobanks/biorepositories and an increase in research and development spending in the biotech and pharma sectors.

Growth Drivers

The increase in the demand for lab automation will power the acceptance of these systems. Owing to the fast enhancements in molecular genomics and genetic testing procedures, the data produced by labs has quickly increased.

Also, the requirement for automated lab systems will increase as a result of the shift in the preference in the direction of personalized care, increase in numerous cancer genomics investigations, and development in patient engagement needs.

The industry will benefit from the governing authorities' snowballing pressure for the disposition of lab automation systems.

Healthcare processes have turned out to be reproducible and repeatable with the mounting acceptance of process automation and robotics.

The growing usage of high-output technologies has made it likely to assess experimental results more competently, which advances the general efficiency of laboratory operations.

The ECM Category has the Fastest Growth

The ECM category will grow the fastest in the years to come, with a 12% rate in the industry.

The acceptance of ECM is growing as it provides comprehensive and integrated solutions for meeting the rising issues in the healthcare sector.

ECM provides a centralized method for seizing, making, organizing, accessing, and examining the whole ecosystem of knowledge assets, media, and e-documents in a company.

Moreover, companies in the industry offer more than a few services associated with ECM, such as design, consultation, installation, and upkeep of these software solutions.

Cloud-Based Category Leads the Market

On the basis of delivery mode, the cloud-based category had the largest share of 55%, in 2023, and it will continue like this in the years to come as well.

This is for the reason that cloud-deployed LIMs make available space on on-premises computer devices, by stowing vast data amounts offsite, which likewise makes it easier for retrieving it whenever the client requires it.

Cloud-based LIMs can be availed of in three ways, PaaS, IaaS, and SaaS. On the SaaS platform, IBM offers its Watson Analytics services. Additionally, LabVantage Solutions Inc. and Core Informatics provide cloud-based services for LIMS.

North America Makes the Most Revenue

North America leads the industry with about 40% share, in 2023, and it will power at a robust rate by the end of this decade. The accessibility of cutting-edge IT infra, together with high levels of digital literacy and legislation boosting the acceptance of lab information systems, is the key driver for the growth of the industry.

Furthermore, the growing healthcare expenditures and the necessity to stem this surge have brought about the usage of LIMSs across industries. Additionally, the existence of well-established pharma businesses and the mounting requirement to control operational costs associated with info management and analysis are the main drivers for the expansion of the industry.

Competitive Analysis

With an increase in the requirement for COVID-19 tests, clinical labs extended the degree of their operations. In turn, the large number of patients led to challenges in emerging, regulating, and validating novel approaches for testing patients, along with gathering, stowing, examining, and rapidly and precisely reporting massive volumes of patient test data.

LIM is important for coping with the requirement for COVID-19 tests in clinical labs, which encouraged product acceptance during the outbreak of the pandemic.

Product Code: 12880

Table of Contents

Chapter 1. Research Scope

  • 1.1. Research Objectives
  • 1.2. Market Definition
  • 1.3. Analysis Period
  • 1.4. Market Size Breakdown by Segments
    • 1.4.1. Market size breakdown, by product
    • 1.4.2. Market size breakdown, by delivery mode
    • 1.4.3. Market size breakdown, by component
    • 1.4.4. Market size breakdown, by industry
    • 1.4.5. Market size breakdown, by region
    • 1.4.6. Market size breakdown, by country
  • 1.5. Market Data Reporting Unit
    • 1.5.1. Value
  • 1.6. Key Stakeholders

Chapter 2. Research Methodology

  • 2.1. Secondary Research
    • 2.1.1. Paid
    • 2.1.2. Unpaid
    • 2.1.3. P&S Intelligence database
  • 2.2. Primary Research
  • 2.3. Market Size Estimation
  • 2.4. Data Triangulation
  • 2.5. Currency Conversion Rates
  • 2.6. Assumptions for the Study
  • 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

  • 5.1. Market Dynamics
    • 5.1.1. Trends
    • 5.1.2. Drivers
    • 5.1.3. Restraints/challenges
    • 5.1.4. Impact analysis of drivers/restraints
  • 5.2. Impact of COVID-19
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Bargaining power of buyers
    • 5.3.2. Bargaining power of suppliers
    • 5.3.3. Threat of new entrants
    • 5.3.4. Intensity of rivalry
    • 5.3.5. Threat of substitutes

Chapter 6. Global Market

  • 6.1. Overview
  • 6.2. Market Revenue, by Product (2017-2030)
  • 6.3. Market Revenue, by Delivery Mode (2017-2030)
  • 6.4. Market Revenue, by Component (2017-2030)
  • 6.5. Market Revenue, by Industry (2017-2030)
  • 6.6. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

  • 7.1. Overview
  • 7.2. Market Revenue, by Product (2017-2030)
  • 7.3. Market Revenue, by Delivery Mode (2017-2030)
  • 7.4. Market Revenue, by Component (2017-2030)
  • 7.5. Market Revenue, by Industry (2017-2030)
  • 7.6. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

  • 8.1. Overview
  • 8.2. Market Revenue, by Product (2017-2030)
  • 8.3. Market Revenue, by Delivery Mode (2017-2030)
  • 8.4. Market Revenue, by Component (2017-2030)
  • 8.5. Market Revenue, by Industry (2017-2030)
  • 8.6. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

  • 9.1. Overview
  • 9.2. Market Revenue, by Product (2017-2030)
  • 9.3. Market Revenue, by Delivery Mode (2017-2030)
  • 9.4. Market Revenue, by Component (2017-2030)
  • 9.5. Market Revenue, by Industry (2017-2030)
  • 9.6. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

  • 10.1. Overview
  • 10.2. Market Revenue, by Product (2017-2030)
  • 10.3. Market Revenue, by Delivery Mode (2017-2030)
  • 10.4. Market Revenue, by Component (2017-2030)
  • 10.5. Market Revenue, by Industry (2017-2030)
  • 10.6. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

  • 11.1. Overview
  • 11.2. Market Revenue, by Product (2017-2030)
  • 11.3. Market Revenue, by Delivery Mode (2017-2030)
  • 11.4. Market Revenue, by Component (2017-2030)
  • 11.5. Market Revenue, by Industry (2017-2030)
  • 11.6. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

  • 12.1. Overview
  • 12.2. Market Revenue, by Product (2017-2030)
  • 12.3. Market Revenue, by Delivery Mode (2017-2030)
  • 12.4. Market Revenue, by Component (2017-2030)
  • 12.5. Market Revenue, by Industry (2017-2030)

Chapter 13. Canada Market

  • 13.1. Overview
  • 13.2. Market Revenue, by Product (2017-2030)
  • 13.3. Market Revenue, by Delivery Mode (2017-2030)
  • 13.4. Market Revenue, by Component (2017-2030)
  • 13.5. Market Revenue, by Industry (2017-2030)

Chapter 14. Germany Market

  • 14.1. Overview
  • 14.2. Market Revenue, by Product (2017-2030)
  • 14.3. Market Revenue, by Delivery Mode (2017-2030)
  • 14.4. Market Revenue, by Component (2017-2030)
  • 14.5. Market Revenue, by Industry (2017-2030)

Chapter 15. France Market

  • 15.1. Overview
  • 15.2. Market Revenue, by Product (2017-2030)
  • 15.3. Market Revenue, by Delivery Mode (2017-2030)
  • 15.4. Market Revenue, by Component (2017-2030)
  • 15.5. Market Revenue, by Industry (2017-2030)

Chapter 16. U.K. Market

  • 16.1. Overview
  • 16.2. Market Revenue, by Product (2017-2030)
  • 16.3. Market Revenue, by Delivery Mode (2017-2030)
  • 16.4. Market Revenue, by Component (2017-2030)
  • 16.5. Market Revenue, by Industry (2017-2030)

Chapter 17. Italy Market

  • 17.1. Overview
  • 17.2. Market Revenue, by Product (2017-2030)
  • 17.3. Market Revenue, by Delivery Mode (2017-2030)
  • 17.4. Market Revenue, by Component (2017-2030)
  • 17.5. Market Revenue, by Industry (2017-2030)

Chapter 18. Spain Market

  • 18.1. Overview
  • 18.2. Market Revenue, by Product (2017-2030)
  • 18.3. Market Revenue, by Delivery Mode (2017-2030)
  • 18.4. Market Revenue, by Component (2017-2030)
  • 18.5. Market Revenue, by Industry (2017-2030)

Chapter 19. Japan Market

  • 19.1. Overview
  • 19.2. Market Revenue, by Product (2017-2030)
  • 19.3. Market Revenue, by Delivery Mode (2017-2030)
  • 19.4. Market Revenue, by Component (2017-2030)
  • 19.5. Market Revenue, by Industry (2017-2030)

Chapter 20. China Market

  • 20.1. Overview
  • 20.2. Market Revenue, by Product (2017-2030)
  • 20.3. Market Revenue, by Delivery Mode (2017-2030)
  • 20.4. Market Revenue, by Component (2017-2030)
  • 20.5. Market Revenue, by Industry (2017-2030)

Chapter 21. India Market

  • 21.1. Overview
  • 21.2. Market Revenue, by Product (2017-2030)
  • 21.3. Market Revenue, by Delivery Mode (2017-2030)
  • 21.4. Market Revenue, by Component (2017-2030)
  • 21.5. Market Revenue, by Industry (2017-2030)

Chapter 22. Australia Market

  • 22.1. Overview
  • 22.2. Market Revenue, by Product (2017-2030)
  • 22.3. Market Revenue, by Delivery Mode (2017-2030)
  • 22.4. Market Revenue, by Component (2017-2030)
  • 22.5. Market Revenue, by Industry (2017-2030)

Chapter 23. South Korea Market

  • 23.1. Overview
  • 23.2. Market Revenue, by Product (2017-2030)
  • 23.3. Market Revenue, by Delivery Mode (2017-2030)
  • 23.4. Market Revenue, by Component (2017-2030)
  • 23.5. Market Revenue, by Industry (2017-2030)

Chapter 24. Brazil Market

  • 24.1. Overview
  • 24.2. Market Revenue, by Product (2017-2030)
  • 24.3. Market Revenue, by Delivery Mode (2017-2030)
  • 24.4. Market Revenue, by Component (2017-2030)
  • 24.5. Market Revenue, by Industry (2017-2030)

Chapter 25. Mexico Market

  • 25.1. Overview
  • 25.2. Market Revenue, by Product (2017-2030)
  • 25.3. Market Revenue, by Delivery Mode (2017-2030)
  • 25.4. Market Revenue, by Component (2017-2030)
  • 25.5. Market Revenue, by Industry (2017-2030)

Chapter 26. Saudi Arabia Market

  • 26.1. Overview
  • 26.2. Market Revenue, by Product (2017-2030)
  • 26.3. Market Revenue, by Delivery Mode (2017-2030)
  • 26.4. Market Revenue, by Component (2017-2030)
  • 26.5. Market Revenue, by Industry (2017-2030)

Chapter 27. South Africa Market

  • 27.1. Overview
  • 27.2. Market Revenue, by Product (2017-2030)
  • 27.3. Market Revenue, by Delivery Mode (2017-2030)
  • 27.4. Market Revenue, by Component (2017-2030)
  • 27.5. Market Revenue, by Industry (2017-2030)

Chapter 28. U.A.E. Market

  • 28.1. Overview
  • 28.2. Market Revenue, by Product (2017-2030)
  • 28.3. Market Revenue, by Delivery Mode (2017-2030)
  • 28.4. Market Revenue, by Component (2017-2030)
  • 28.5. Market Revenue, by Industry (2017-2030)

Chapter 29. Competitive Landscape

  • 29.1. List of Market Players and their Offerings
  • 29.2. Competitive Benchmarking of Key Players
  • 29.3. Product Benchmarking of Key Players
  • 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

  • 30.1. LabVantage Solutions Inc.
    • 30.1.1. Business overview
    • 30.1.2. Product and service offerings
    • 30.1.3. Key financial summary
  • 30.2. Thermo Fisher Scientific Inc.
    • 30.2.1. Business overview
    • 30.2.2. Product and service offerings
    • 30.2.3. Key financial summary
  • 30.3. STARLIMS Corporation
    • 30.3.1. Business overview
    • 30.3.2. Product and service offerings
    • 30.3.3. Key financial summary
  • 30.4. PerkinElmer Inc.
    • 30.4.1. Business overview
    • 30.4.2. Product and service offerings
    • 30.4.3. Key financial summary
  • 30.5. LABWORKS LLC
    • 30.5.1. Business overview
    • 30.5.2. Product and service offerings
    • 30.5.3. Key financial summary
  • 30.6. Autoscribe Informatics
    • 30.6.1. Business overview
    • 30.6.2. Product and service offerings
    • 30.6.3. Key financial summary
  • 30.7. Dassault Systemes SE
    • 30.7.1. Business overview
    • 30.7.2. Product and service offerings
    • 30.7.3. Key financial summary
  • 30.8. Agilent Technologies Inc.
    • 30.8.1. Business overview
    • 30.8.2. Product and service offerings
    • 30.8.3. Key financial summary
  • 30.9. Cerner Corporation
    • 30.9.1. Business overview
    • 30.9.2. Product and service offerings
    • 30.9.3. Key financial summary
  • 30.10. McKesson Corporation
    • 30.10.1. Business overview
    • 30.10.2. Product and service offerings
    • 30.10.3. Key financial summary

Chapter 31. Appendix

  • 31.1. Abbreviations
  • 31.2. Sources and References
  • 31.3. Related Reports
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!